Literature DB >> 26360874

A novel mutation af Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy.

L Licchetta1, F Bisulli2, M Fietz3, M L Valentino2, M Morbin4, B Mostacci5, K L Oliver6, S F Berkovic6, P Tinuper2.   

Abstract

Juvenile neuronal-ceroid-lipofuscinosis (JNCL) is a lysosomal storage disease caused by mutations in CLN3. The most frequent mutation is a 1.02-kb deletion that, when homozygous, causes the classical clinical presentation. Patients harboring mutations different than the major deletion show a marked clinical heterogeneity, including protracted disease course with possible involvement of extraneuronal tissues. Cardiac involvement is relatively rare in JNCL and it is usually due to myocardial storage of ceroid-lipofuscinin. Only recently, histopathological findings of autophagic vacuolar myopathy (AVM) were detected in JNCL patients with severe cardiomyopathy. We describe a 35-year-old male showing a delayed-classic JNCL with visual loss in childhood and neurological manifestations only appearing in adult life. He had an unusual CLN3 genotype with an unreported deletion (p.Ala349_Leu350del) and the known p.His315Glnfs*67 mutation. Autophagic vacuolar myopathy was shown by muscle biopsy. At clinical follow-up, moderately increased CPK levels were detected whereas periodic cardiac assessments have been normal to date. Adult neurologists should be aware of protracted JNCL as cause of progressive neurological decline in adults. The occurrence of autophagic vacuolar myopathy necessitates periodic cardiac surveillance, which is not usually an issue in classic JNCL due to early neurological death.
Copyright © 2015 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Autophagic vacuolar myopathy; CLN3; Delayed-classic JNCL; Juvenile neuronal ceroid lipofuscinosis (JNCL)

Mesh:

Substances:

Year:  2015        PMID: 26360874     DOI: 10.1016/j.ejmg.2015.09.002

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  4 in total

1.  Juvenile Batten Disease (CLN3): Detailed Ocular Phenotype, Novel Observations, Delayed Diagnosis, Masquerades, and Prospects for Therapy.

Authors:  Genevieve A Wright; Michalis Georgiou; Anthony G Robson; Naser Ali; Ambreen Kalhoro; Sm Kleine Holthaus; Nikolas Pontikos; Ngozi Oluonye; Emanuel R de Carvalho; Magella M Neveu; Richard G Weleber; Michel Michaelides
Journal:  Ophthalmol Retina       Date:  2019-11-13

2.  Differential gene expression analysis following olfactory learning in honeybee (Apis mellifera L.).

Authors:  Muhammad Fahad Raza; Muhammad Anwar; Arif Husain; Muhmmad Rizwan; Zhiguo Li; Hongyi Nie; Pavol Hlaváč; M Ajmal Ali; Ahmed Rady; Songkun Su
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

3.  Autophagic vacuolar myopathy is a common feature of CLN3 disease.

Authors:  Josefine Radke; Randi Koll; Esther Gill; Lars Wiese; Angela Schulz; Alfried Kohlschütter; Markus Schuelke; Christian Hagel; Werner Stenzel; Hans H Goebel
Journal:  Ann Clin Transl Neurol       Date:  2018-10-14       Impact factor: 4.511

Review 4.  The CLN3 gene and protein: What we know.

Authors:  Myriam Mirza; Anna Vainshtein; Alberto DiRonza; Uma Chandrachud; Luke J Haslett; Michela Palmieri; Stephan Storch; Janos Groh; Niv Dobzinski; Gennaro Napolitano; Carolin Schmidtke; Danielle M Kerkovich
Journal:  Mol Genet Genomic Med       Date:  2019-09-30       Impact factor: 2.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.